Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Apr 15, 2025; 17(4): 102913
Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.102913
Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.102913
Figure 5 Comparison of chemotherapeutic effects in groups with high and low F-box protein 22 levels based on The Cancer Genome Atlas-colon adenocarcinoma cohort and analysed by R package oncoPredict.
IC50 was calculated for tipifarnib. FBXO22: F-box protein 22.
- Citation: Lu XF, Zhang HW, Chang X, Guo YZ. F-box protein 22: A prognostic biomarker for colon cancer associated with immune infiltration and chemotherapy resistance. World J Gastrointest Oncol 2025; 17(4): 102913
- URL: https://www.wjgnet.com/1948-5204/full/v17/i4/102913.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i4.102913